International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma-Reference-Cited by-同舟云学术

International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma

Published:2002-03 Issue:3 Volume:46 Page:884-886
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Aarnoutse Rob E.¹,Verweij-van Wissen Corrien P. W. G. M.¹,van Ewijk-Beneken Kolmer Eleonora W. J.¹,Wuis Eveline W.¹,Koopmans Peter P.²,Hekster Yechiel A.¹,Burger David M.¹

Affiliation:

1. Department of Clinical Pharmacy

2. Department of General Internal Medicine, University Medical Centre Nijmegen, Nijmegen, The Netherlands

Abstract

ABSTRACT An international interlaboratory quality control program for measurement of antiretroviral drugs was initiated. The first round was confined to protease inhibitors and showed large variability in the performance of participating laboratories. The results demonstrate the need for and utility of an ongoing quality control program in this area of bioanalysis.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.46.3.884-886.2002

Reference7 articles.

1. Aarnoutse, R. E., C. P. W. G. M. Verweij-van Wissen, W. J. M. Underberg, J. Kleinnijenhuis, Y. A. Hekster, and D. M. Burger. 2001. High-performance liquid chromatography of HIV protease inhibitors in human biological matrices. J. Chromatogr. B764:363-384.

2. Acosta, E. P., T. N. Kakuda, R. C. Brundage, P. L. Anderson, and C. V. Fletcher. 2000. Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors. Clin. Infect. Dis.30:S151-S159.

3. Back, D. J., S. H. Khoo, S. E. Gibbons, M. G. Barry, and C. Merry. 2000. Therapeutic drug monitoring of antiretrovirals in human immunodeficiency virus infection. Ther. Drug. Monit.22:122-126.

4. Barry, M. G., F. Mulcahy, C. Merry, S. Gibbons, and D. J. Back. 1999. Pharmacokinetics and potential interactions amongst anti-retroviral agents used to treat patients with HIV infection. Clin. Pharmacokinet.36:289-304.

5. Hugen, P. W. H., C. P. W. G. M. Verweij-van Wissen, D. M. Burger, E. W. Wuis, P. P. Koopmans, and Y. A. Hekster. 1999. Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography. J. Chromatogr. B727:139-149.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics, Short-term Safety and Efficacy of the Approved Once-daily Darunavir/Ritonavir Dosing Regimen in HIV-infected Children;Pediatric Infectious Disease Journal;2018-10

2. A design for external quality assessment for the analysis of thiopurine drugs: pitfalls and opportunities;Clinical Chemistry and Laboratory Medicine (CCLM);2018-08-15

3. Measuring Plasma Concentrations of Ribavirin: First Report From a Quality Control Program;Therapeutic Drug Monitoring;2016-10

4. An interlaboratory quality control programme for the measurement of tuberculosis drugs;European Respiratory Journal;2015-04-16

5. Poor Performance of Laboratories Assaying Newly Developed Antiretroviral Agents;Therapeutic Drug Monitoring;2014-12